AGP Executive Report
Last update: 4 hours agoHIV Prevention Breakthrough: At the 26th International AIDS Conference in Rio, Merck’s once-monthly PrEP candidate MK-8527 (now called alimatravir) was discussed as potentially manufacturable for about US$3 per person per year, though a licensing deal reportedly leaves out much of Latin America including Paraguay’s region. Primary Care Partnership: The Bahamas has joined PAHO-led the Alliance for Primary Health Care in the Americas, aiming to strengthen primary care and health system transformation through coordinated investment and technical cooperation. Eye Health Access in Venezuela: Paraguay-linked regional health cooperation echoes as Misión Milagro delivered cataract surgeries to 102 patients in Nueva Esparta, highlighting how “visual health days” can expand access. Children’s Health & Development: Paraguay’s Ministry of Children and Adolescents launched its Toy Bank campaign for Children’s Day (16 August), collecting toys, books, and board games to support play that boosts physical, emotional, and social development. Local Health Infrastructure & Oversight: FEMA is reviewing COVID-19 spending tied to Hawaii Lt. Gov. Sylvia Luke’s corruption indictment, with possible repayment or enforcement if improper or fraudulent costs are found—an accountability reminder for public health funds. HIV & Health Policy Watch: The conference also noted phase III trials for alimatravir across multiple countries, with Paraguay listed among those with trial sites.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
